Author: Slot, Ed; Hogema, Boris M.; Reusken, Chantal B. E. M.; Reimerink, Johan H.; Molier, Michel; Karregat, Jan H. M.; IJlst, Johan; Novotný, Věra M. J.; van Lier, René A. W.; Zaaijer, Hans L.
Title: Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands Cord-id: zstmf1iv Document date: 2020_11_12
ID: zstmf1iv
Snippet: The world is combating an ongoing COVID-19 pandemic with health-care systems, society and economies impacted in an unprecedented way. It is unclear how many people have contracted the causative coronavirus (SARS-CoV-2) unknowingly and are asymptomatic. Therefore, reported COVID-19 cases do not reflect the true scale of outbreak. Here we present the prevalence and distribution of antibodies to SARS-CoV-2 in a healthy adult population of the Netherlands, which is a highly affected country, using a
Document: The world is combating an ongoing COVID-19 pandemic with health-care systems, society and economies impacted in an unprecedented way. It is unclear how many people have contracted the causative coronavirus (SARS-CoV-2) unknowingly and are asymptomatic. Therefore, reported COVID-19 cases do not reflect the true scale of outbreak. Here we present the prevalence and distribution of antibodies to SARS-CoV-2 in a healthy adult population of the Netherlands, which is a highly affected country, using a high-performance immunoassay. Our results indicate that one month into the outbreak (i) the seroprevalence in the Netherlands was 2.7% with substantial regional variation, (ii) the hardest-hit areas showed a seroprevalence of up to 9.5%, (iii) the seroprevalence was sex-independent throughout age groups (18–72 years), and (iv) antibodies were significantly more often present in younger people (18–30 years). Our study provides vital information on the extent of exposure to SARS-CoV-2 in a country where social distancing is in place.
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and additional association: 1
- acute ards respiratory distress syndrome and additional testing: 1, 2, 3
- acute ards respiratory distress syndrome and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- acute ards respiratory distress syndrome and logistic regression model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute ards respiratory distress syndrome and low positive: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute ards respiratory distress syndrome and low prevalence: 1, 2
- additional association and logistic regression: 1, 2, 3
- additional association and logistic regression analysis: 1
- additional testing and logistic regression: 1, 2, 3, 4
- additional testing and logistic regression analysis: 1, 2, 3
- additional testing and logistic regression model: 1
- additional testing and low positive: 1, 2, 3
- additional testing and low prevalence: 1, 2, 3
- lockdown intervention and logistic regression: 1
- lockdown social distancing and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- lockdown social distancing and logistic regression analysis: 1, 2, 3
- lockdown social distancing and logistic regression model: 1
- logistic regression and low risk people: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date